Thrombolysis for Ischemic Stroke Beyond the 4.5-Hour Window: A Meta-Analysis of Randomized Clinical Trials
Thrombolyse beim ischämischen Schlaganfall jenseits des 4,5-Stunden-Fensters: Metaanalyse randomisierter klinischer Studien
Stroke · 2025-03 · 56 (3) · 580-590
DOI: 10.1161/strokeaha.124.048536 ↗Auf einen Blick
Acht RCTs zeigen jenseits von 4,5 Stunden nach Symptombeginn höhere Chancen auf gute funktionelle Ergebnisse unter IVT als unter Standardversorgung. Zugleich stieg die Rate symptomatischer intrazerebraler Blutungen.
Fragestellung
Verbessert intravenöse Thrombolyse bei ischämischem Schlaganfall nach 4,5 Stunden ohne mechanische Thrombektomie die funktionellen Ergebnisse im Vergleich zur Standardversorgung?
Methode
Systematische Suche in MEDLINE, Embase, Cochrane und ClinicalTrials.gov nach RCTs; Metaanalyse mit Random-Effects-Modell.
Ergebnisse
8 RCTs mit 1742 Patient:innen. Exzellentes Outcome: OR 1,43 (95 %-KI 1,17–1,75). Gutes Outcome: OR 1,36 (95 %-KI 1,12–1,66). sICH: OR 4,25 (95 %-KI 1,67–10,84). Mortalität nach 90 Tagen: OR 1,28 (95 %-KI 0,87–1,89).
Schlussfolgerung der Autor:innen
IVT jenseits von 4,5 Stunden führte ohne MT zu höheren Chancen auf exzellente und gute funktionelle Ergebnisse gegenüber Standardversorgung, bei höherer sICH-Rate und nicht signifikant erhöhter Mortalität.
Kernaussagen
- Exzellentes Outcome häufiger unter IVT: OR 1,43 (95 %-KI 1,17–1,75)
- sICH häufiger unter IVT: OR 4,25 (95 %-KI 1,67–10,84)
- Mortalität nach 90 Tagen nicht signifikant verschieden
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Metaanalyse in der Zeitschrift Stroke, 2025-03. Verfasst von Ahmet Günkan und 15 weiteren Autor:innen. Beteiligte Einrichtung: Independent Researcher (A.G.). Hauptthemen laut MEDLINE: Ischemic Stroke, Thrombolytic Therapy, Fibrinolytic Agents. Die Arbeit wurde bisher 80-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Themen: Schlaganfall
Abstract (Originalsprache)
BACKGROUND: A minority of patients with stroke qualify for intravenous thrombolysis (IVT) within 4.5-hour window. The safety and efficacy of IVT beyond this period have not been well studied. METHODS: We systematically searched MEDLINE, Embase, Cochrane, and ClinicalTrials.gov for relevant randomized clinical trials. Randomized clinical trials comparing IVT versus standard medical care in patients with ischemic stroke beyond 4.5 hours of symptom onset or last known well without mechanical thrombectomy (MT) were included. Primary outcomes were excellent (modified Rankin Scale score of 0–1) and good (modified Rankin Scale score of 0–2) functional outcomes at 90 days, symptomatic intracerebral hemorrhage (sICH), and death at 90 days. Pooled odds ratios (ORs) with 95% CIs were calculated using a random-effects model. Heterogeneity was assessed by Q test and quantified by I ² values. RESULTS: Eight randomized clinical trials (1742 patients; mean age, 69.8±9 years, 63.5% men) were included. Compared with standard medical care, IVT achieved higher rates of excellent (OR, 1.43 [95% CI, 1.17–1.75]; Q =2.30; P =0.94; I 2 =0%) and good functional outcomes (OR, 1.36 [95% CI, 1.12–1.66]; Q =2.07; P =0.96; I 2 =0%) at 90 days but also increased sICH rates (OR, 4.25 [95% CI, 1.67–10.84], Q =0.48; P =0.99; I 2 =0%). Mortality at 90 days did not significantly differ between treatment groups (OR, 1.28 [95% CI, 0.87–1.89]; Q =4.63; P =0.59; I 2 =0%). Subanalyses yielded numerically higher odds of excellent functional outcomes when patients were selected with perfusion imaging (3 studies, OR, 1.45 [95% CI, 1.08–1.94]) compared with diffusion-weighted imaging–fluid-attenuated inversion recovery mismatch (3 studies, OR, 1.34 [95% CI, 0.94–1.91]) and when treated with tenecteplase (3 studies, OR, 1.47 [95% CI, 1.06–2.04]) compared with alteplase (5 studies, OR, 1.38 [95% CI, 1.08–1.78]). CONCLUSIONS: IVT for ischemic stroke beyond 4.5 hours, without MT, led to increased odds of excellent and good functional outcomes compared with standard medical care, despite higher odds of sICH, and a nonsignificant numerical increase in mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Independent Researcher (A.G.).
- Department of Neurosurgery, Lenox Hill Hospital/Northwell Health, New York, NY (M.Y.F., C.F., Y.S.).
- School of Medicine, Catholic University of Brasilia (M.V.).
- Department of Neuroradiology, Henri Mondor Hospital, Créteil, France (L.S.).
- Academic Department of Surgery, School of Medicine, Universidad Peruana Cayetano Heredia, Lima, Peru (J.E.B.-B.).
- Federal University of Minas Gerais, Belo Horizonte, Brazil (L.J.C.C.).
ORCID-Profile: Ahmet Günkan, Marcio Yuri Ferreira, Marina Vilardo, Luca Scarcia, Jhon E Bocanegra-Becerra, Leonardo Januario Campos Cardoso, Luis F Fabrini Paleare, Gustavo de Oliveira Almeida, Gabriel Semione, Christian Ferreira, Gabriele Ciccio, Adnan Mujanovic, Pascal Jabbour, Thanh N Nguyen, Jean-Claude Baron
Zitieren
APA
Günkan, A., Ferreira, M. Y., Vilardo, M., Scarcia, L., Bocanegra-Becerra, J. E., Cardoso, L. J. C., Fabrini Paleare, L. F., de Oliveira Almeida, G., Semione, G., Ferreira, C., Ciccio, G., Mujanovic, A., Jabbour, P., Serulle, Y., Nguyen, T. N., & Baron, J. C. (2025). Thrombolysis for Ischemic Stroke Beyond the 4.5-Hour Window: A Meta-Analysis of Randomized Clinical Trials. Stroke, 56(3), 580-590. https://doi.org/10.1161/strokeaha.124.048536
Vancouver
Günkan A, Ferreira MY, Vilardo M, Scarcia L, Bocanegra-Becerra JE, Cardoso LJC, et al. Thrombolysis for Ischemic Stroke Beyond the 4.5-Hour Window: A Meta-Analysis of Randomized Clinical Trials. Stroke. 2025;56(3):580-590. doi:10.1161/strokeaha.124.048536
BibTeX
@article{Gnkan2025,
author = {Günkan, Ahmet and Ferreira, Marcio Yuri and Vilardo, Marina and Scarcia, Luca and Bocanegra-Becerra, Jhon E and Cardoso, Leonardo Januario Campos and Fabrini Paleare, Luis F and de Oliveira Almeida, Gustavo and Semione, Gabriel and Ferreira, Christian and Ciccio, Gabriele and Mujanovic, Adnan and Jabbour, Pascal and Serulle, Yafell and Nguyen, Thanh N and Baron, Jean-Claude},
title = {Thrombolysis for Ischemic Stroke Beyond the 4.5-Hour Window: A Meta-Analysis of Randomized Clinical Trials},
journal = {Stroke},
year = {2025},
volume = {56},
number = {3},
pages = {580--590},
doi = {10.1161/strokeaha.124.048536}
}
EUVIMED